News About: Pharm. Industry
Pharmaceutical industry calling for more tax cuts on R&D spendingThe government’s long-term plans for the development of new drugs should focus on more tax cuts levied on research and development (R&D) reserves, facility investment for resear...
|
US FDA okays Ketotop patch as OTC productPacific Pharma says its anti-inflammatory pain reliever Ketotop (ketoprofen transdermal patch) has been registered to the US Food and Drug Administration as an over-the-counter ...
|
Battle gets fiercer over Cozaar generic Market
Major pharmaceutical companies have waged fiercer campaigns to raise market share of their Cozaar (losartan potassium) generics amid stronger competition.
Dong-A, Yuhan, Hanmi and Chong Kun Dang started aggressive ...
Pharmaceutical production was 9.3 million won in 1940
The nation's drug output totaled 9.34 million won in 1940, compared with 13.4 trillion won last year, according to the National Statistical Office (NSO).
“Despite three currency denominations and increased commodit...
Novartis opens clinical research officeNovartis Korea says its clinical research office has recently opened in Seoul Asan Hospital to promote local clinical research level through a closer collaboration.
This is t...
|
Dong-A ships first batch of Zydena to RussiaDong-A Pharmaceutical Co., Korea's largest pharmaceutical company, said on December 12 that it has started shipping 135,000 tablets of Zydena, an erectile dysfunction drug, to ...
|
Chong Kun Dang release Penzal seriesChong Kun Dang Pharmaceutical has put out a series of Penzal in the form of tablet and drink, a popular antipyretic and anti-inflammatory agent.
The newly released Penzal-Q a...
|
Korea’s efforts for self-purification attract IFPMA members
The Korean pharmaceutical firms’ launching of a compliance program (CP) for fair trade, together with efforts for self-purification to root out illicit practices, draw keen interest from members of the International F...
Restructuring drive unlikely to pick up pace
Restructuring of major pharmaceutical firms is expected to lose momentum as they intend to put emphasis on maintaining the number of employees with professional jobs.
Industry sources say pharmaceutical firms have ...
Weak won wreak havoc on drugmakers
Leading pharmaceutical companies are having serious difficulties, hit by the won's fall against the greenback and other major currencies.
“We are in an emergency to offset mounting losses from the weaker won in the...
